ClinicalTrials.Veeva

Menu

Predictive Clinical and Biological Parameters in Breast Cancer (BC-BIO)

I

Institut Paoli-Calmettes

Status

Enrolling

Conditions

Breast Cancer

Treatments

Genetic: molecular alteration

Study type

Interventional

Funder types

Other

Identifiers

NCT01521676
BC-BIO/IPC 2009-005

Details and patient eligibility

About

Research of predictive clinical and biological factors in breast cancer :

genomic, proteomic, mutation

Enrollment

750 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • breast cancer
  • age > 18
  • signed informed consent

Exclusion criteria

  • emergency

Trial design

Primary purpose

Basic Science

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

750 participants in 1 patient group

breast cancer
Experimental group
Description:
blood and tumor sample
Treatment:
Genetic: molecular alteration

Trial contacts and locations

2

Loading...

Central trial contact

Dominique GENRE, MD; Jihane PAKRADOUNI, PharmD PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems